Patent · US Active

Monoclonal Olfml-3 antibodies and uses thereof

US10808026B2 · kind B2 · utility

0Cited by

2References

15Claims

0Family size

Assignee

Research Development Foundation · US

Inventors

Beat Imhof · Geneva, CH
Marijana Miljkovic-Licina · Geneva, CH
Philippe Hammel · Geneva, CH

Key dates

Filing date	Oct 9, 2014
Grant date	Oct 20, 2020
Priority date	—
Expiry date	Jul 10, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/76
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein are monoclonal antibodies against Olfml-3. In some aspects, methods for treating angiogenesis-related conditions, such as cancer, are provided comprising administering an Olfml-3-binding antibody of the embodiments.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.